Product image of Флудеоксиглюкоза (18f) Ge Healthcare (Fludeoxyglucose (18f)) supplied by GNH India

Флудеоксиглюкоза (18f) Ge Healthcare

Active Ingredient:
Fludeoxyglucose (18f)
Origin:
EU

Флудеоксиглюкоза (18f) Ge Healthcare (Fludeoxyglucose (18f))

Fludeoxyglucose (18F) is a radiopharmaceutical used in PET imaging for metabolic activity assessment. This sterile, injectable solution helps visualize glucose metabolism in tissues. Short half-life requires prompt use after preparation. Suitable for oncology, neurology and cardiology scans.

Manufacturer / TM Owner

Ge Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Fludeoxyglucose (18F) is used in positron emission tomography (PET) imaging to evaluate metabolic activity within the body. It helps identify areas of abnormal glucose metabolism often associated with cancer, neurological disorders or cardiac conditions. The radiotracer accumulates in tissues with high metabolic rates, aiding in diagnosis and treatment planning.

Side Effects

  • After intravenous injection, Fludeoxyglucose (18F) distributes throughout the body and accumulates in tissues with high glucose uptake. The radioactive signal is detected by PET scanners to create detailed images of metabolic activity. Patients typically experience no immediate physiological effects from the radiotracer itself.

Precautions & Warnings

  • Fludeoxyglucose (18F) should be handled by trained medical professionals in controlled clinical settings. Pregnant or breastfeeding individuals should avoid exposure due to radiation risks. Patients are advised to minimize close contact with others for several hours post-injection to reduce radiation exposure to others.

Avoid Interactions

  • No known drug interactions exist with Fludeoxyglucose (18F) as it is a radiopharmaceutical rather than a conventional medication. However, recent chemotherapy, radiation therapy or other diagnostic procedures may affect imaging results. Patients should disclose all medications and recent medical procedures to their healthcare provider.

Frequently Asked Questions

It is a radiotracer used in PET imaging to assess metabolic activity in tissues, commonly for cancer, neurological or cardiac evaluations.

It is administered intravenously by healthcare professionals in a clinical setting equipped for PET imaging.

The radiotracer itself typically causes no immediate physiological effects, though patients may experience minor discomfort at the injection site.

Patients are generally advised to arrange transportation home as sedation or fatigue may occur depending on individual response.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fludeoxyglucose (18f)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT